Carlyle buys stake in Mak-System

Mak-System also announced the appointment of Philippe Houssiau as CEO following a vote by shareholders.

The investment will support the company's growth, including its international expansion, according to a statement.

Carlyle deployed equity via Carlyle Europe Partners V (CEP V) and Carlyle European Technology Partners IV (CETP IV). CEP V held a final close in October 2019 on €6.4bn and was 23% deployed at the time, according to Unquote Data. CETP IV held a final close in January 2019 on €1.35bn and was 6% deployed as of December 2019.

Company
Mak-System produces software designed to support blood chain management, ranging from donation to transfusion. The business has an international client base that includes blood centres, plasma centres, transfusion services, tissue banks, stem cell labs and cell and gene therapy centres.

Founded in 1984 by Simon Kiskovski, the company operates in 65 countries and has facilities in a number of locations, including the US. It employs 48 staff, according to LinkedIn. The company generates revenues of $13m, according to Zoominfo.

People
Mak-System – Simon Kiskovski (founder); Philippe Houssiau (CEO).
The Carlyle Group – Jonathan Zafrani (managing director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Benelux
• Technology
• Belgium
• Carlyle Group